ArticleGastroenterology research and practice2013
The Prevalence of Helicobacter pylori Infection Decreases with Older Age in Atrophic Gastritis.
Article in Gastroenterology research and practice, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 25 citations in OpenAlex.
- Endoscopic mucosal phenotypes and endoscopic Sydney system gastritis assessment in relation toJGH open : an open access journal of gastroenterology and hepatology · 2024Article
- Impact of Helicobacter pylori eradication on the gastric microbiome.Gut pathogens · 2021Article
- Prevalence and Potential Risk Factors of Helicobacter pylori Infection among Asymptomatic Individuals in Kazakhstan.Asian Pacific journal of cancer prevention : APJCP · 2021Article
- Novel treatment for gastric intestinal metaplasia, a precursor to cancer.JGH open : an open access journal of gastroenterology and hepatology · 2020Article
- Prevention of gastric cancer by Helicobacter pylori eradication: A review from Japan.Cancer medicine · 2019Review
- Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing.Helicobacter · 2019Article
- Helicobacter pylori antibody and pepsinogen testing for predicting gastric microbiome abundance.PloS one · 2019Article
- Exploring current status of Helicobacter pylori infection in different age groups of patients with dyspepsia.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2017Article
- The prevalence of Helicobacter pylori is decreasing in Iranian patients.Gastroenterology and hepatology from bed to bench · 2015Article
- Long-term effects and benefits ofSaudi journal of gastroenterology : official journal of the Saudi Gastroenterology AssociationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The clinical pathological characteristics of 3969 adult patients with chronic atrophic gastritis were retrospectively studied. The positivity of intestinal metaplasia and dysplasia in atrophic gastric specimens increased with age; however, H. pylori positivity and inflammatory activity decreased significantly with increased age. H. pylori infection was present in 21.01% of chronic atrophic gastritis patients, and 92.33% of the subjects with H. pylori infection were found to have simultaneous inflammatory activity. The intestinal metaplasia and dysplasia positivity markedly increased as the degree of gastric atrophy increased. In conclusion, the incidence of H. pylori infection decreased with age and correlated significantly with inflammatory activity in atrophic gastritis patients. The intestinal metaplasia and dysplasia positivity notably increased as the degree of gastric atrophy increased. Large population-based prospective studies are needed to better understand the progression of CAG.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.